Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,506.48
(
-1.51%
)
US TECH 100
23,484.80
(
-0.99%
)
Dow Jones
45,577.47
(
-0.96%
)
Brent Oil
106.93
(
0.00%
)
Bitcoin
70,721.01
(
0.29%
)
News Focus
News Focus
Post# of 257266
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

biomaven0

Send PM Follow Ignore
Followers 82
Posts 4778
Boards Moderated 0
Alias Born 02/27/2007

biomaven0

Re: oldberkeley post# 127011

Wednesday, 09/21/2011 2:38:03 PM

Wednesday, September 21, 2011 2:38:03 PM

Post# of 257266

it's impossible for TEVA (insert Amphastar if applicable) or any company to manufacture enoxaparin without violating certain of MNTA's patents during the process



Sanofi manufactures enox without violating any of MNTA's patents, so clearly it is possible to do so.

I'm guessing the delayed launch is simply because they got taken by surprise by the FDA action so they need to build stocks.

Peter
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today